TUPEA04 | HIV-1 infection: virus and host wrestle for control of the SUMOylation system | Poster exhibition | Understanding and targeting persistent HIV reservoirs |
TUPEA05 | Emergence of genetically-distinct HIV-1 populations is associated with transient virological control during analytical interruption of antiretroviral therapy | Poster exhibition | Understanding and targeting persistent HIV reservoirs |
TUPEA06 | The Rainbow 5-plex digital PCR assay improves quantification of the viral reservoir resulting in a better understanding of the HIV-1 proviral landscape | Poster exhibition | Understanding and targeting persistent HIV reservoirs |
TUPEA07 | Linking inducible HIV-1 reservoir to rebound after treatment interruption | Poster exhibition | Understanding and targeting persistent HIV reservoirs |
TUPEA08 | Potent, HIV-specific latency reversal through CRISPR activation delivered by lipid nanoparticles exhibiting a high efficiency of transfecting resting CD4+ T cells with minimal toxicity | Poster exhibition | Understanding and targeting persistent HIV reservoirs |
TUPEA09 | Characterization of the intact and defective HIV-1 subtype C reservoir in South African women and men at baseline and 96 weeks after ART-therapy | Poster exhibition | Understanding and targeting persistent HIV reservoirs |
TUPEA10 | Methylseleninic acid induces HIV viral reactivation from latently infected cells in vitro and ex vivo | Poster exhibition | Understanding and targeting persistent HIV reservoirs |